Edinburgh centre for inflammation research

Savill, John (Principal Investigator)
Haslett, Christopher (Co-investigator)

Status	Finished
Effective start/end date	30/09/04 → 30/09/10

Funding

MRC: £1,017,824.00
MRC: £1,518,324.00

2 Article
1 Literature review

Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation
Chapman, K. E., Coutinho, A. E., Zhang, Z., Kipari, T., Savill, J. S. & Seckl, J. R., Sept 2013, In: Journal of Steroid Biochemistry and Molecular Biology. 137, p. 82-92 11 p.
Research output: Contribution to journal › Literature review › peer-review

Open Access
File
11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis
Kipari, T., Hadoke, P. W. F., Iqbal, J., Man, T.-Y., Miller, E., Coutinho, A. E., Zhang, Z., Sullivan, K. M., Mitic, T., Livingstone, D. E. W., Schrecker, C., Samuel, K., White, C. I., Bouhlel, M. A., Chinetti-Gbaguidi, G., Staels, B., Andrew, R., Walker, B. R., Savill, J. S. & Chapman, K. E. & 1 others, Seckl, J. R., Apr 2013, In: The FASEB Journal. 27, 4, p. 1519-1531 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Mast Cells Express 11 beta-hydroxysteroid Dehydrogenase Type 1: A Role in Restraining Mast Cell Degranulation: a role in restraining mast cell degranulation
Coutinho, A. E., Brown, J. K., Yang, F., Brownstein, D. G., Gray, M., Seckl, J. R., Savill, J. S. & Chapman, K. E., 18 Jan 2013, In: PLoS ONE. 8, 1, 8 p., ARTN e54640.
Research output: Contribution to journal › Article › peer-review

Open Access
File